Skip to content

A non-interventional, post-marketing survey study of healthcare professionals based on their experience using a high-fiber enteral feeding.

A non-interventional, post-marketing survey study of healthcare professionals based on their experience using a high-fiber enteral feeding. - A non-interventional, post-marketing survey study of healthcare professionals based on their experience using a high-fiber enteral feeding.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000048410
Enrollment
200
Registered
2022-07-20
Start date
2022-07-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation

Interventions

None listed

Sponsors

Nestle Health Science Company, Nestle Japan Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: At the time of enrollment, healthcare professionals who meet all of the following criteria will be considered research subjects 1) Physicians and nurses who fully understand the content of the study and have given their free and voluntary consent to participate in this study via the website. 2) Physicians and nurses who have used ISOCAL Fibecare for at least two weeks in patients with constipation symptoms (including patients with diarrhea caused by laxatives). 3) Physicians/nurses who can fill in and answer the questionnaire by themselves.

Exclusion criteria

Exclusion criteria: No setting

Design outcomes

Primary

MeasureTime frame
1) Background of responding healthcare professionals 2) Background of patients using ISOCAL Fibecare 3) Experience with ISOCAL Fibecare 4) Changes in nutritional status of patients treated with ISOCAL Fibecare 5) Changes in defecation status of patients using ISOCAL Fibecare 6) Changes in constipation treatment in patients using ISOCAL Fibecare 7) Changes in complications in patients with ISOCAL Fibecare 8) Changes in defecation care status of patients with ISOCAL Fibecare 9) Intention to use ISOCAL Fibecare

Countries

Japan

Contacts

Public ContactHiroki Takano

Nestle Health Science Company, Nestle Japan Ltd. Marketing & Medical Affairs

Hiroki.Takano@jp.nestle.com03-5769-6227

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026